Yellow Fever Pipeline Review | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | Sanofi Pasteur SA, Janssen, Pfizer Inc., BIOCRYST PHARMACEUTICALS, Tychan Pte, Johnson & Johnson Services, Inc., Tak

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Yellow Fever pipeline constitutes 10+ key companies continuously working towards developing 10+ Yellow Fever treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

"Yellow Fever Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Yellow Fever Market.

The Yellow Fever Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Yellow Fever Pipeline Report: https://www.delveinsight.com/sample-request/yellow-fever-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Yellow Fever treatment therapies with a considerable amount of success over the years.
• Yellow Fever companies working in the treatment market are Emergex Vaccines, Atea Pharmaceuticals, AstriVax, Tysana Pte Ltd, Najit Technologies, Inc, Sanofi Pasteur, and others, are developing therapies for the Yellow Fever treatment
• Emerging Yellow Fever therapies in the different phases of clinical trials are- naNO-Flu, AT-752, Yellow fever vaccine, TY014, HydroVax-002 YFV, SP 0218, and others are expected to have a significant impact on the Yellow Fever market in the coming years.
• In October 2021, Sanofi Pasteur has launched a trial named "Controlled Study of Immunogenicity and Safety of the Investigational vYF Candidate Vaccine in Comparison to Stamaril in Adults." The VYF03 trial is a phase II randomized study comprising two arms: an active-controlled (Stamaril) arm and an observer-blind, multi-center study. Its primary aim is to evaluate the non-inferiority of the immune response, specifically assessing seroconversion rates between the investigational vaccine candidate vYF and the licensed Stamaril in adults aged 18 to 60 years in Europe (EU).
• In January 2020, Sanofi Pasteur has commenced a trial named "Safety, Tolerability, and Immunogenicity Dose-ranging Study of the Investigational Yellow Fever Vaccine (vYF) Candidate Vaccine in Adults." The main aims of this study are to delineate the safety profiles of three different dosages of vYF and YF-VAX® within 28 days after vaccination and throughout the 6-month period up to the post-vaccination visit on Day 180.

Yellow Fever Overview
Acute viral hemorrhagic disease known as yellow fever is native to tropical regions of Africa and Latin America. It might be challenging to differentiate cases from other viral hemorrhagic fevers such dengue, hantavirus, or arenavirus. Acute viral hemorrhagic fever, or yellow fever, is spread by infected mosquitoes.

Get a Free Sample PDF Report to know more about Yellow Fever Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/yellow-fever-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Emerging Yellow Fever Drugs Under Different Phases of Clinical Development Include:
• naNO-Flu: Emergex Vaccines
• AT-752: Atea Pharmaceuticals
• Yellow fever vaccine: AstriVax
• TY014: Tysana Pte Ltd
• HydroVax-002 YFV: Najit Technologies, Inc
• SP 0218: Sanofi Pasteur

Yellow Fever Route of Administration
Yellow Fever pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Intramuscular
• Intravenous
• Subcutaneous
• Topical.
• Molecule Type

Yellow Fever Molecule Type
Yellow Fever Products have been categorized under various Molecule types, such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
• Product Type

Yellow Fever Pipeline Therapeutics Assessment
• Yellow Fever Assessment by Product Type
• Yellow Fever By Stage and Product Type
• Yellow Fever Assessment by Route of Administration
• Yellow Fever By Stage and Route of Administration
• Yellow Fever Assessment by Molecule Type
• Yellow Fever by Stage and Molecule Type

DelveInsight's Yellow Fever Report covers around 5+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Further Yellow Fever product details are provided in the report. Download the Yellow Fever pipeline report to learn more about the emerging Yellow Fever therapies at:
https://www.delveinsight.com/sample-request/yellow-fever-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key companies in the Yellow Fever Therapeutics Market include:
Key companies developing therapies for Yellow Fever are - Sanofi Pasteur SA, Janssen, Pfizer Inc., BIOCRYST PHARMACEUTICALS, INC., Tychan Pte. Ltd., Johnson & Johnson Services, Inc., Takeda Pharmaceutical Company Limited, Bayer AG, GlaxoSmithKline plc, Bio-Manguinhos, Institut Pasteur de Dakar, FSUE Chumakov, and others.

Yellow Fever Pipeline Analysis:
The Yellow Fever pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Yellow Fever with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Yellow Fever Treatment.
• Yellow Fever key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Yellow Fever Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Yellow Fever market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Yellow Fever drugs and therapies-
https://www.delveinsight.com/sample-request/yellow-fever-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Yellow Fever Pipeline Market Drivers
• Increasing prevalence of Yellow fever, increase in research and development activities are some of the important factors that are fueling the Yellow Fever Market.

Yellow Fever Pipeline Market Barriers
• However, side effects of Yellow fever vaccination, limited Treatment options and other factors are creating obstacles in the Yellow Fever Market growth.

Scope of Yellow Fever Pipeline Drug Insight
• Coverage: Global
• Key Yellow Fever Companies: Emergex Vaccines, Atea Pharmaceuticals, AstriVax, Tysana Pte Ltd, Najit Technologies, Inc, Sanofi Pasteur, and others
• Key Yellow Fever Therapies: naNO-Flu, AT-752, Yellow fever vaccine, TY014, HydroVax-002 YFV, SP 0218, and others
• Yellow Fever Therapeutic Assessment: Yellow Fever current marketed and Yellow Fever emerging therapies
• Yellow Fever Market Dynamics: Yellow Fever market drivers and Yellow Fever market barriers

Request for Sample PDF Report for Yellow Fever Pipeline Assessment and clinical trials-
https://www.delveinsight.com/sample-request/yellow-fever-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Yellow Fever Report Introduction
2. Yellow Fever Executive Summary
3. Yellow Fever Overview
4. Yellow Fever- Analytical Perspective In-depth Commercial Assessment
5. Yellow Fever Pipeline Therapeutics
6. Yellow Fever Late Stage Products (Phase II/III)
7. Yellow Fever Mid Stage Products (Phase II)
8. Yellow Fever Early Stage Products (Phase I)
9. Yellow Fever Preclinical Stage Products
10. Yellow Fever Therapeutics Assessment
11. Yellow Fever Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Yellow Fever Key Companies
14. Yellow Fever Key Products
15. Yellow Fever Unmet Needs
16 . Yellow Fever Market Drivers and Barriers
17. Yellow Fever Future Perspectives and Conclusion
18. Yellow Fever Analyst Views
19. Appendix
20. About DelveInsight

Related Reports:

Yellow Fever Market https://www.delveinsight.com/report-store/yellow-fever-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Yellow Fever Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),

Yellow Fever Epidemiology https://www.delveinsight.com/report-store/yellow-fever-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Yellow Fever Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports:
Oncology Drugs Market
https://www.delveinsight.com/report-store/oncology-drugs-market
Oncology Drugs Market By Therapy Type (Chemotherapy, Hormonal Therapy, Targeted Therapy [Gene Therapy And Immunotherapy], And Others), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Blood Cancers, And Others), By End User (Hospitals, Specialty Clinics, And Others), and by geography is estimated to grow at a healthy CAGR forecast till 2028 due to rising prevalence of various cancers such as lung and breast cancers and growing demand for targeted therapies for cancer treatment.

Biologics Market
https://www.delveinsight.com/report-store/biologics-market
Biologics Market By Product Type (Cell-Based Biologics, Gene-Based Biologics, Monoclonal Antibodies, Vaccines, Recombinant Protiens, And Others), By Application (Oncology, Immunology, Infectious Diseases, Neurological Diseases, And Others), By Manufacturing Type (In-House And Outsourced), and by geography is expected to grow at a steady CAGR forecast till 2028 owing to rising prevalence of autoimmune disorders such as rheumatoid arthiritis and genetic disorders.

Biosimilar Market
https://www.delveinsight.com/report-store/biosimilars-market
Biosimilars Market By Product Class (Monoclonal Antibodies, Recombinant Hormone/Proteins, Anti-Inflammatory Agents, Immunomodulators, And Others), By Manufacturing Type (In-House And Outsourced/Contract), By Application (Autoimmune Diseases, Blood Disorders, Oncology, Infectious Diseases, And Others), by geography, is projected to expand at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders such as autoimmune disorders, cancers, among others and increasing demand for biosimilar drugs owing to their cost-effectiveness.

Cancer Immunotherapy Market
https://www.delveinsight.com/report-store/cancer-immunotherapy-market
Cancer Immunotherapy Market By Type (Monoclonal Antibodies, Immunomodulators, Cancer Vaccines, Checkpoint Inhibitors, And Others), By Indication (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, And Others), By End-User (Hospitals And Clinics, Specialty Centers, And Others), and by geography is expected to rise at a significant CAGR forecast till 2027 owing to the accelerating prevalence of cancers and surging healthcare expenditure across the globe

Companion Diagnostics Market
https://www.delveinsight.com/report-store/companion-diagnostics-market
Companion Diagnostics Market By Type (Product [Assays, Kits & Reagents And Instruments], and Services), Technology (Immunohistochemistry (IHC), Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and Others), Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, and Others), End-User (Hospitals, Diagnostic Labs, and Others), and Geography is expected to grow at a noteworthy CAGR till 2028 owing to the increase in the cancer burden across the globe and the growing focus on personalized medicines.

Telemedicine Service Market
https://www.delveinsight.com/report-store/telemedicine-service-market
Telemedicine Service Market By Service Type (Tele Consulting And Tele Monitoring), By Application (Telepathology, Telecardiology, Teleradiology, Teledermatology, Telepsychiatry, Other Services), By End-User (Healthcare Facilities And Homecare), by geography, is projected to grow at a significant CAGR forecast till 2028 owing to the sudden outbreak of covid-19 pandemic and shifting focus for reducing the burden of healthcare cost.

DNA Sequencing Market
https://www.delveinsight.com/report-store/dna-sequencing-market
DNA Sequencing Market By Products & Services (Instruments, Consumbales, And Services), By Technology (Sanger Sequencing, Next-Generation Sequencing, And Long-Read Sequencing), By Application (Disease Diagnosis, Precision Medicine, And Research), By End User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical Companies, And Academic Institutes), and by geography is estimated to grow at an appreciable CAGR forecast till 2028 owing to rising prevalence of genetic disorders and growing popularity of precision medicine.

Next Generation Sequencing Market
https://www.delveinsight.com/report-store/next-generation-sequencing-market
Next-Generation Sequencing Market By Product Type (Instruments, Reagents & Consumables And Services), By Sequencing Type (Whole-Genome Sequencing, Whole-Exome Sequencing, Rna Sequencing, Targeted Sequencing, De-Novo Sequencing, Others), By Application (Diagnostic, Drug Discovery, Agriculture & Animal Research, Others), By End-User (Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Academic & Research Institute), by geography, is expected to grow at a significant CAGR forecast till 2028 owing to the rising application of next-generation sequencing (NGS) technology in clinical diagnosis and advancement in NGS platforms.

Active Pharmaceutical Ingredient Market
https://www.delveinsight.com/report-store/active-pharmaceutical-ingredient-api-market
Active Pharmaceutical Ingredient (API) Market By Type (Innovative And Generic), By Manufacturer Type (Captive And Merchant), By Synthesis Type (Synthetic And Biotech), By Application (Oncology, Cardiology, Pulmonology, Neurology, Orthopedic, Opthalmology, And Others), by geography is estimated to register growth at remarkable CAGR forecast till 2027 owing to rising prevalence of various diseases such as diabetes and growing focus on drug development

Clinical Diagnostics Market
https://www.delveinsight.com/report-store/clinical-diagnostics-market
Clinical Diagnostics Market By Type (Products [Instruments, Kits & Reagents], Services), Test (Complete Blood Count (CBC), Metabolic Panel, Lipid Panel, Renal Panel, Liver Panel, Infectious Disease Testing, and Others), End-User (Hospitals, Pathology Labs, and Others), and Geography, is expected to expand at a significant CAGR till 2028 owing to the growing cases of various chronic diseases & infectious diseases across the globe and rise in the integration of technological advancements in the product portfolio.

Contact Us:
Gaurav Bora
gbora@delveinsight.com
+1(919)321-6187
Healthcare Consulting
https://www.delveinsight.com/consulting-services

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.